PMC:7405836 / 98782-98993 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T896","span":{"begin":74,"end":82},"obj":"Disease"},{"id":"T897","span":{"begin":74,"end":78},"obj":"Disease"},{"id":"T898","span":{"begin":83,"end":93},"obj":"Disease"}],"attributes":[{"id":"A896","pred":"mondo_id","subj":"T896","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A897","pred":"mondo_id","subj":"T897","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A898","pred":"mondo_id","subj":"T898","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"There is no currently licensed specific antiviral treatment for MERS- and SARS-CoV infections, and the main focus in clinical settings remains on lessening clinical signs and providing supportive care (183–186)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T892","span":{"begin":108,"end":113},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"There is no currently licensed specific antiviral treatment for MERS- and SARS-CoV infections, and the main focus in clinical settings remains on lessening clinical signs and providing supportive care (183–186)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T10366","span":{"begin":40,"end":49},"obj":"Chemical"}],"attributes":[{"id":"A61511","pred":"chebi_id","subj":"T10366","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"There is no currently licensed specific antiviral treatment for MERS- and SARS-CoV infections, and the main focus in clinical settings remains on lessening clinical signs and providing supportive care (183–186)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T685","span":{"begin":0,"end":211},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"There is no currently licensed specific antiviral treatment for MERS- and SARS-CoV infections, and the main focus in clinical settings remains on lessening clinical signs and providing supportive care (183–186)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2670","span":{"begin":74,"end":93},"obj":"Disease"}],"attributes":[{"id":"A2670","pred":"tao:has_database_id","subj":"2670","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"There is no currently licensed specific antiviral treatment for MERS- and SARS-CoV infections, and the main focus in clinical settings remains on lessening clinical signs and providing supportive care (183–186)."}